IBN vs. RDY
IBN (ICICI Bank Limited) and RDY (Dr. Reddy's Laboratories Limited) are both stocks. IBN operates in Banks - Regional (Financial Services), while RDY operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, IBN returned 16.92%/yr vs 5.05%/yr for RDY. At a 0.33 correlation, their price movements are largely independent.
Performance
IBN vs. RDY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBN achieves a -4.97% return, which is significantly lower than RDY's 1.92% return. Over the past 10 years, IBN has outperformed RDY with an annualized return of 16.92%, while RDY has yielded a comparatively lower 5.05% annualized return.
IBN
- 1D
- -0.74%
- 1M
- 9.01%
- YTD
- -4.97%
- 6M
- -6.07%
- 1Y
- -12.81%
- 3Y*
- 8.34%
- 5Y*
- 11.18%
- 10Y*
- 16.92%
RDY
- 1D
- 2.88%
- 1M
- 5.22%
- YTD
- 1.92%
- 6M
- 0.56%
- 1Y
- -5.95%
- 3Y*
- 6.41%
- 5Y*
- 1.19%
- 10Y*
- 5.05%
IBN vs. RDY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBN ICICI Bank Limited | -4.97% | 0.57% | 26.32% | 9.80% | 11.27% | 33.57% | -1.52% | 47.01% | 6.25% | 44.03% |
RDY Dr. Reddy's Laboratories Limited | 1.92% | -10.53% | 14.13% | 36.47% | -19.74% | -7.33% | 76.80% | 8.45% | 0.37% | -16.46% |
Correlation
The correlation between IBN and RDY is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Apr 11, 2001 | 0.33 |
Fundamentals
IBN:
$102.62B
RDY:
$11.95B
IBN:
₹149.87
RDY:
₹51.45
IBN:
17.89
RDY:
26.33
IBN:
0.86
RDY:
1.11
IBN:
3.11
RDY:
3.35
IBN:
2.68
RDY:
3.06
IBN:
₹3.13T
RDY:
₹337.10B
IBN:
₹2.18T
RDY:
₹177.79B
IBN:
₹774.07B
RDY:
₹74.65B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBN vs. RDY — Risk / Return Rank
IBN
RDY
IBN vs. RDY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ICICI Bank Limited (IBN) and Dr. Reddy's Laboratories Limited (RDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBN | RDY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.37 | ||
| Sortino ratioReturn per unit of downside risk | -0.59 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 0.98 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | -0.30 | -0.19 |
| Martin ratioReturn relative to average drawdown | -0.92 | -0.57 | -0.35 |
Loading charts...
Drawdowns
IBN vs. RDY - Drawdown Comparison
The maximum IBN drawdown since its inception was -86.09%, which is greater than RDY's maximum drawdown of -60.62%. Use the drawdown chart below to compare losses from any high point for IBN and RDY.
Loading charts...
Drawdown Indicators
| IBN | RDY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.09% | -60.62% | -25.47% |
Max Drawdown (1Y)Largest decline over 1 year | -26.20% | -19.58% | -6.62% |
Max Drawdown (3Y)Largest decline over 3 years | -26.20% | -26.61% | +0.41% |
Max Drawdown (5Y)Largest decline over 5 years | -26.24% | -35.25% | +9.01% |
Max Drawdown (10Y)Largest decline over 10 years | -55.05% | -47.13% | -7.92% |
Current DrawdownCurrent decline from peak | -17.07% | -14.50% | -2.57% |
Average DrawdownAverage peak-to-trough decline | -27.99% | -21.92% | -6.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.98% | 10.46% | +3.52% |
Volatility
IBN vs. RDY - Volatility Comparison
The current volatility for ICICI Bank Limited (IBN) is 6.02%, while Dr. Reddy's Laboratories Limited (RDY) has a volatility of 7.17%. This indicates that IBN experiences smaller price fluctuations and is considered to be less risky than RDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBN | RDY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.02% | 7.17% | -1.15% |
Volatility (6M)Calculated over the trailing 6-month period | 17.15% | 18.16% | -1.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.78% | 23.55% | -2.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.64% | 23.40% | +0.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.52% | 26.62% | +4.90% |
Dividends
IBN vs. RDY - Dividend Comparison
IBN's dividend yield for the trailing twelve months is around 0.88%, more than RDY's 0.64% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBN ICICI Bank Limited | 0.88% | 0.84% | 0.80% | 0.81% | 0.57% | 0.27% | 0.00% | 0.19% | 0.43% | 0.79% | 1.98% | 4.01% |
RDY Dr. Reddy's Laboratories Limited | 0.64% | 0.65% | 0.60% | 1.39% | 1.48% | 1.04% | 0.46% | 0.71% | 0.00% | 0.78% | 0.62% | 0.63% |
Financials
IBN vs. RDY - Financials Comparison
This section allows you to compare key financial metrics between ICICI Bank Limited and Dr. Reddy's Laboratories Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IBN vs. RDY - Profitability Comparison
IBN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ICICI Bank Limited reported a gross profit of 623.06B and revenue of 846.14B. Therefore, the gross margin over that period was 73.6%.
RDY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a gross profit of 34.22B and revenue of 76.33B. Therefore, the gross margin over that period was 44.8%.
IBN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ICICI Bank Limited reported an operating income of 208.13B and revenue of 846.14B, resulting in an operating margin of 24.6%.
RDY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported an operating income of 473.25M and revenue of 76.33B, resulting in an operating margin of 0.6%.
IBN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ICICI Bank Limited reported a net income of 147.55B and revenue of 846.14B, resulting in a net margin of 17.4%.
RDY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a net income of 2.24B and revenue of 76.33B, resulting in a net margin of 2.9%.
Frequently Asked Questions
IBN and RDY have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RDY has higher volatility (7.17%) compared to IBN (6.02%). In terms of maximum drawdown, IBN dropped -86.09% vs RDY's -60.62%.
RDY currently has the higher Sharpe Ratio (-0.25 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBN and RDY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer